Mazor Robotics (MZOR) Secures New Orders For Renaissance System, ADRs Sunk 5%

Israel-based medical equipment developer Mazor Robotics (MZOR) Wednesday said it has received new purchase orders for four Renaissance systems, two in the U.S. and two in international markets. Of the four systems, one included the recently launched brain surgery module.

Renaissance is a surgical guidance system for spine procedure.

Mazor Robotics Ltd is engaged in the development, production and marketing of medical devices for supporting surgical procedures in the field of orthopedics and neurosurgery. MZOR American Depositary Receipts were down by almost 5% in recent pre-market trading on Wednesday and closed at $18.12 on Tuesday.



Jennifer McKinney, CFA, is an equity analyst for The Downtown Leader. If you have a great story idea for Jennifer McKinney, you can write at [ ].